The Drug Information Association (DIA), in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the American Association of Pharmaceutical Scientists, will host the 2nd Conference on Oligonucleotide-based Therapeutics (September 22 - 24; Falls Church, VA).
Horsham, PA (PRWEB) August 15, 2008 -- The http://www.diahome.org/ [Drug Information Association (DIA)]], in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the American Association of Pharmaceutical Scientists, will host the http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=14730&eventType=Meeting [2nd Conference on Oligonucleotide-based Therapeutics] (September 22 - 24; Falls Church, VA).
"Attendees can share product development and regulatory information in the areas of nonclinical, chemistry, manufacturing and control (CMC), and clinical development of Oligonucleotide-based therapeutic drugs with industry experts and international regulators," says Program Co-chair David H. Schubert, Vice President of Regulatory Affairs, Logical Therapeutics, Inc.
Sessions will discuss:
About the www.diahome.org [Drug Information Association (DIA)]
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.
Joe.Krasowski @ diahome.org
# # #
Read the full story at http://www.prweb.com/releases/Oligonucleotide-Based/Therapeutics/prweb1213554.htm
Copyright©2008 Vocus, Inc.
All rights reserved